Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Priority Technology Holdings
PRTH
Concentration Risk %
Concentration Risk % at other companies
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
Weis Markets
WMK
100%
0.0pp
Innoviva, Inc.
INVA
36%
+7.0pp
Strattec Security
STRT
0.5%
0.0pp
Other financials
Income statement
See full
Revenue
$249.6M
+11.1%
Gross profit
$98.8M
+13.2%
Operating income
$33.4M
+2.3%
Net income
$9.8M
+18.0%
EPS (diluted)
$0.12
+20.0%
Balance sheet
See full
Cash & equivalents
$1.5B
+39.4%
Total debt
$1.0B
+13.6%
Total equity
-$89.9M
+43.2%
Total assets
$2.5B
+30.4%
Cash flow
See full
Operating cash flow
$23.8M
+139%
CapEx
$5.5M
+8.4%
Free cash flow
$18.3M
+277%
Valuation
See full
Market cap
$577.31M
-7.2%
Enterprise value
$171.86M
-65.7%
P/E
10.1×
-12.9×
P/S
0.6×
-0.1×
Profitability
See full
Gross margin
39.5%
+1.8pp
Operating margin
14.5%
-0.8pp
Net margin
5.8%
+2.8pp
FCF margin
9.1%
+2.1pp
Returns & leverage
See full
Return on equity
-103%
—
Debt / equity
-11.6×
—
Current ratio
1.1×
0.0×